201 related articles for article (PubMed ID: 19771395)
21. Nuclear estrogen receptor-mediated Notch signaling and GPR30-mediated PI3K/AKT signaling in the regulation of endometrial cancer cell proliferation.
Wei Y; Zhang Z; Liao H; Wu L; Wu X; Zhou D; Xi X; Zhu Y; Feng Y
Oncol Rep; 2012 Feb; 27(2):504-10. PubMed ID: 22075757
[TBL] [Abstract][Full Text] [Related]
22. [Effect of Notch1 on cell cycle, apoptosis and migration of laryngeal squamous cell carninoma cell line Hep-2].
Jiao J; Li S
Zhonghua Zhong Liu Za Zhi; 2012 Feb; 34(2):104-9. PubMed ID: 22780927
[TBL] [Abstract][Full Text] [Related]
23. Growth suppression induced by Notch1 activation involves Wnt-beta-catenin down-regulation in human tongue carcinoma cells.
Duan L; Yao J; Wu X; Fan M
Biol Cell; 2006 Aug; 98(8):479-90. PubMed ID: 16608439
[TBL] [Abstract][Full Text] [Related]
24. Activated Notch signaling augments cell growth in hepatocellular carcinoma via up-regulating the nuclear receptor NR4A2.
Zhu B; Sun L; Luo W; Li M; Coy DH; Yu L; Yu W
Oncotarget; 2017 Apr; 8(14):23289-23302. PubMed ID: 28423575
[TBL] [Abstract][Full Text] [Related]
25. Inhibition of endothelial cell proliferation by Notch1 signaling is mediated by repressing MAPK and PI3K/Akt pathways and requires MAML1.
Liu ZJ; Xiao M; Balint K; Soma A; Pinnix CC; Capobianco AJ; Velazquez OC; Herlyn M
FASEB J; 2006 May; 20(7):1009-11. PubMed ID: 16571776
[TBL] [Abstract][Full Text] [Related]
26. Interruption of β-catenin suppresses the EGFR pathway by blocking multiple oncogenic targets in human glioma cells.
Yue X; Lan F; Yang W; Yang Y; Han L; Zhang A; Liu J; Zeng H; Jiang T; Pu P; Kang C
Brain Res; 2010 Dec; 1366():27-37. PubMed ID: 20969832
[TBL] [Abstract][Full Text] [Related]
27. siRNA targeting Notch-1 decreases glioma stem cell proliferation and tumor growth.
Wang J; Wang C; Meng Q; Li S; Sun X; Bo Y; Yao W
Mol Biol Rep; 2012 Mar; 39(3):2497-503. PubMed ID: 21667253
[TBL] [Abstract][Full Text] [Related]
28. Suppression of renal cell carcinoma growth by inhibition of Notch signaling in vitro and in vivo.
Sjölund J; Johansson M; Manna S; Norin C; Pietras A; Beckman S; Nilsson E; Ljungberg B; Axelson H
J Clin Invest; 2008 Jan; 118(1):217-28. PubMed ID: 18079963
[TBL] [Abstract][Full Text] [Related]
29. PDK1 Mediates
Sambandam V; Frederick MJ; Shen L; Tong P; Rao X; Peng S; Singh R; Mazumdar T; Huang C; Li Q; Pickering CR; Myers JN; Wang J; Johnson FM
Clin Cancer Res; 2019 Jun; 25(11):3329-3340. PubMed ID: 30770351
[TBL] [Abstract][Full Text] [Related]
30. Valproic acid activates notch-1 signaling and regulates the neuroendocrine phenotype in carcinoid cancer cells.
Greenblatt DY; Vaccaro AM; Jaskula-Sztul R; Ning L; Haymart M; Kunnimalaiyaan M; Chen H
Oncologist; 2007 Aug; 12(8):942-51. PubMed ID: 17766653
[TBL] [Abstract][Full Text] [Related]
31. Downregulation of PIK3CB by siRNA suppresses malignant glioma cell growth in vitro and in vivo.
Pu P; Kang C; Zhang Z; Liu X; Jiang H
Technol Cancer Res Treat; 2006 Jun; 5(3):271-80. PubMed ID: 16700623
[TBL] [Abstract][Full Text] [Related]
32. Notch-1 regulates Akt signaling pathway and the expression of cell cycle regulatory proteins cyclin D1, CDK2 and p21 in T-ALL cell lines.
Guo D; Ye J; Dai J; Li L; Chen F; Ma D; Ji C
Leuk Res; 2009 May; 33(5):678-85. PubMed ID: 19091404
[TBL] [Abstract][Full Text] [Related]
33. Notch1 signaling contributes to the oncogenic effect of HBx on human hepatic cells.
Wang F; Xia X; Wang J; Sun Q; Luo J; Cheng B
Biotechnol Lett; 2013 Jan; 35(1):29-37. PubMed ID: 22986536
[TBL] [Abstract][Full Text] [Related]
34. Notch1 is a potential therapeutic target for the treatment of human hepatitis B virus X protein-associated hepatocellular carcinoma.
Sun Q; Wang R; Wang Y; Luo J; Wang P; Cheng B
Oncol Rep; 2014 Feb; 31(2):933-9. PubMed ID: 24336972
[TBL] [Abstract][Full Text] [Related]
35. Inhibitory effect of curcumin on oral carcinoma CAL-27 cells via suppression of Notch-1 and NF-κB signaling pathways.
Liao S; Xia J; Chen Z; Zhang S; Ahmad A; Miele L; Sarkar FH; Wang Z
J Cell Biochem; 2011 Apr; 112(4):1055-65. PubMed ID: 21308734
[TBL] [Abstract][Full Text] [Related]
36. Growth inhibitory effect of rapamycin in Hodgkin-lymphoma cell lines characterized by constitutive NOTCH1 activation.
Nagy N; Hajdu M; Márk Á; Király PA; Tóth M; Dankó T; Csóka M; Sebestyén A
Tumour Biol; 2016 Oct; 37(10):13695-13704. PubMed ID: 27473087
[TBL] [Abstract][Full Text] [Related]
37. ErbB2 induces Notch1 activity and function in breast cancer cells.
Lindsay J; Jiao X; Sakamaki T; Casimiro MC; Shirley LA; Tran TH; Ju X; Liu M; Li Z; Wang C; Katiyar S; Rao M; Allen KG; Glazer RI; Ge C; Stanley P; Lisanti MP; Rui H; Pestell RG
Clin Transl Sci; 2008 Sep; 1(2):107-15. PubMed ID: 20443831
[TBL] [Abstract][Full Text] [Related]
38. Different expression levels of DLK1 inversely modulate the oncogenic potential of human MDA-MB-231 breast cancer cells through inhibition of NOTCH1 signaling.
Nueda ML; Naranjo AI; Baladrón V; Laborda J
FASEB J; 2017 Aug; 31(8):3484-3496. PubMed ID: 28461338
[TBL] [Abstract][Full Text] [Related]
39. DEK proto-oncogene is highly expressed in astrocytic tumors and regulates glioblastoma cell proliferation and apoptosis.
Feng T; Liu Y; Li C; Li Z; Cai H
Tumour Biol; 2017 Jul; 39(7):1010428317716248. PubMed ID: 28670979
[TBL] [Abstract][Full Text] [Related]
40. Effect of siRNA-silencing of SALL2 gene on growth, migration and invasion of human ovarian carcinoma A2780 cells.
Miao F; Zhang X; Cao Y; Wang Y; Zhang X
BMC Cancer; 2017 Dec; 17(1):838. PubMed ID: 29228922
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]